Journal
TRANSPLANTATION
Volume 82, Issue 4, Pages 460-465Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.tp.0000231710.37981.64
Keywords
islet transplantation; islet isolation; nonheartbeating donor; ET-Kyoto solution; iodixanol
Categories
Ask authors/readers for more resources
Background. Current success of islet transplantation has led to donor shortage and the need for marginal donor utilization to alleviate this shortage. The goal of this study was to improve the efficacy of islet transplantation using nonheartbeating donors (NHBDs). Methods. First, we used porcine pancreata for the implementation of several strategies and applied to human pancreata. These strategies included ductal injection with trypsin inhibitor for protection of pancreatic ducts, ET-Kyoto solution for pancreas preservation, and Iodixanol for islet purification. Results. These strategies significantly improved both porcine and human islet isolation efficacy. Average 399,469 +/- 36,411 IE human islets were obtained from NHBDs (n = 13). All islet preparations met transplantation criteria and 11 out of 13 cases (85%) were transplanted into six type I diabetic patients for the first time in Japan. All islets started to secrete insulin and all patients showed better blood glucose control without hypoglycemic loss of consciousness. The average HbA1c levels of the six recipients significantly improved from 7.5 +/- 0.4% at transplant to 5.1 +/- 0.2% currently (P < 0.0003). The average insulin amounts of the six recipients significantly reduced from 49.2 +/- 33 units at transplant to 11 +/- 4.4 units (P < 0.0005) and five out of six patients reduced to less than half dose. The first patient is now insulin free, the first such case in Japan. Conclusion. This demonstrates that our current protocol makes it feasible to use NHBDs for islet transplant into type I diabetic patients efficiently.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available